| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF02536553 |
| P698 | PubMed publication ID | 1819720 |
| P2093 | author name string | M Uchida | |
| N Imanishi | |||
| S Morooka | |||
| T Sugasawa | |||
| P2860 | cites work | Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs | Q33454951 |
| Perspectives in platelet-activating factor research | Q39663875 | ||
| Histamine antagonists and asthma | Q40249741 | ||
| Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease | Q40340276 | ||
| New antihistaminic drugs (benadryl, pyribenzamine and neoantergan) in hay fever and other allergic conditions. | Q41081583 | ||
| Pharmacological modulation of bronchial anaphylaxis induced by aerosol challenge in anaesthetized guinea-pigs | Q41971640 | ||
| Prevention of non-specific airway hyperreactivity after allergen challenge in guinea-pigs by the PAF receptor antagonist SDZ 64-412. | Q42084217 | ||
| An in vivo model for measuring antigen-induced SRS-A-mediated bronchoconstriction and plasma SRS-A levels in the guinea-pig | Q42635224 | ||
| Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig | Q43870839 | ||
| A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction | Q46317861 | ||
| The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation | Q46658765 | ||
| Biological effect of orally active platelet-activating factor receptor antagonist SM-10661. | Q46862520 | ||
| Spirometric evaluation of benadryl in asthma. | Q52790041 | ||
| The symptomatic treatment of bronchial asthma and hay fever with benadryl | Q52795600 | ||
| Pulmonary anti-anaphylactic activity of clenbuterol tested on actively and passively sensitized guinea-pigs. | Q53895365 | ||
| Modification of allergen-induced airway obstruction and airway hyperresponsiveness in an allergic rabbit model by the selective platelet-activating factor antagonist, BN 52021. | Q54339868 | ||
| Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs | Q69051904 | ||
| Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation | Q69844549 | ||
| Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids | Q70281112 | ||
| Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites | Q70399643 | ||
| Nonimmunological production of leukotrienes induced by platelet-activating factor | Q70464266 | ||
| SRSA-mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo | Q70930247 | ||
| A method for the fluorometric assay of histamine in tissues | Q78918563 | ||
| P433 | issue | 12 | |
| P921 | main subject | asthma | Q35869 |
| anaphylaxis | Q168800 | ||
| P304 | page(s) | 1301-1304 | |
| P577 | publication date | 1991-12-01 | |
| P1433 | published in | Lipids | Q15756668 |
| P1476 | title | Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs. | |
| P478 | volume | 26 |
| Q71793652 | Effect of the PAF-receptor antagonist SM-12502 on human platelets |
| Q46903442 | Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 2. Effect on antigen-induced dual asthmatic response and infiltration of leukocytes into airways in actively sensitized conscious guinea pigs |
| Q71793649 | Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502 |
| Q40524595 | Platelet activating factor antagonists |
Search more.